Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Calcium, Phosphate and Skeletal Demands in Pregnancy: Study Summary

Previous related pageHow to Read Vitamin D Studies During PregnancyNext related pageVitamin D, Calcium, Phosphate and Skeletal Demands in Pregnancy: Full Evidence Review
Study at a glance

What was the question?

How does vitamin D relate to calcium, phosphate and bone demands during pregnancy? The review separates blood concentrations from mineral absorption, kidney losses and changes in bone.

Who or what was studied?

The evidence includes pregnant women and mouse experiments. A human calcium-absorption study had only five women in its absorption subset. Other research examined vitamin D supplementation, abnormal vitamin D breakdown in mice and mouse responses to phosphate diets.

What did the studies find?

Human calcium absorption increased in the small study. Mice lacking a vitamin D breakdown enzyme had greater calcium absorption and high blood calcium. Separate mouse experiments found phosphate-related hormone responses without measuring maternal vitamin D. A human bone-marker analysis found that the marker rose in both treatment groups, despite a difference in one adjusted comparison.

What are the limits?

Animal findings do not establish a human supplement dose. The reviewed account reports no direct clinical measurements of phosphate absorption during human pregnancy. Blood minerals and bone markers cannot prove maternal bone protection or fewer fractures. The evidence shows adaptation, but leaves important questions about mechanisms and health outcomes unresolved.

Read the full article below ↓

The developing fetal skeleton needs calcium and phosphate. The mother’s body adapts during pregnancy, but a normal blood result cannot show every change in mineral absorption or bone. Human studies and mouse experiments provide different parts of this explanation. The detailed evidence and its limits are in Vitamin D, Calcium, Phosphate and Skeletal Demands in Pregnancy: Full Evidence Review.

What was studied?

The review combines a small human study of calcium absorption, a human vitamin D3 trial, two different mouse investigations and a secondary analysis of maternal bone markers. It also uses an assessed physiological account to explain what is known and uncertain. The mouse studies are not instructions for human supplementation or diet.

Vitamin D and Calcium Physiology describes calcium handling. Vitamin D and Phosphate Regulation explains phosphate, which also contributes to skeletal mineral. Both minerals matter, but evidence about one does not automatically establish what happens to the other.

What did the human studies show?

Cross and colleagues found increased calcium absorption during pregnancy in a very small subset: only five women contributed absorption measurements, with four observations late in pregnancy. This directly measured intestinal uptake, but it did not show that vitamin D alone caused the change. It also did not measure the whole balance between maternal intake, losses, bone and fetal mineral needs.

The Hollis supplementation trial changed vitamin D status without demonstrating significant differences between groups in its reported mineral blood and urine measurements. Those measurements do not establish that every mineral process was unchanged. They also do not prove that maternal bone was protected.

A secondary analysis of the MAVIDOS trial examined a urine marker related to bone breakdown. The marker rose in both groups. One adjusted comparison differed between groups, while the comparison of absolute changes was not significant. The marker did not fall in absolute terms. This analysis did not establish fracture prevention or measure changes in bone from before pregnancy. Some important supplementary analyses were unavailable.

What did the mouse experiments add?

Maekawa and colleagues studied mice missing an enzyme involved in breaking down vitamin D metabolites. During pregnancy, these mice had higher active vitamin D, greater calcium absorption and high blood calcium. This shows an effect of abnormal vitamin D breakdown in mice. It does not show the effect of a supplement in a normal human pregnancy.

The result also does not prove that every pregnancy adaptation requires the vitamin D receptor. An earlier paper’s abstract reports adaptation in mice without that receptor. Its full report was unavailable, so the review retains this contrary observation without claiming to have verified the detailed mechanism.

Sellars and colleagues studied maternal responses to different phosphate diets in mice. They measured changes in phosphate and hormones involved in mineral control. They did not measure maternal vitamin D concentrations or phosphate absorption. This is useful evidence about phosphate regulation, but not proof of a vitamin D-specific effect in humans. The two mouse papers used different experiments from the same research programme.

What remains uncertain?

The reviewed physiological account reports no clinical studies directly measuring phosphate absorption during human pregnancy. Animal findings must not be presented as human measurements. Human pregnancy findings for fibroblast growth factor 23, a hormone involved in phosphate regulation, also differ between studies.

Absorption, kidney losses, bone turnover and the amount of mineral retained in the skeleton are different outcomes. A normal circulating concentration cannot settle all of them. Vitamin D Metabolism at the Cellular Level explains the distinction between vitamin D activation and breakdown, another reason that different experiments cannot be treated as the same intervention.

What does this mean?

Pregnancy creates real mineral demands and measurable adaptation. Vitamin D participates in these processes, but the evidence does not establish one universal mechanism, dose or guarantee of maternal bone protection. Human calcium absorption has some direct evidence; human phosphate absorption during pregnancy is less well established. The most useful interpretation states which mineral, species, pregnancy stage and outcome were actually studied.

Sources and access

This Summary uses its Full Evidence Review’s assessed evidence. The detailed review identifies the four core primary studies, the additional maternal turnover analysis, the abstract-only contrary receptor finding and the reviewed Endotext sections. No new studies or treatment recommendations are added.

Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Cross NA et al. American Journal of Clinical Nutrition. 1995;61:514 to 523.

Maternal loss of 24-hydroxylase causes increased intestinal calcium absorption and hypercalcemia during pregnancy but reduced skeletal resorption during lactation in mice. Maekawa AS et al. Journal of Bone and Mineral Research. 2024;39:1793 to 1808.

Murine Fetal Serum Phosphorus is Set Independent of FGF23 and PTH, Except in the Presence of Maternal Phosphate Loading. Sellars KB et al. Endocrinology. 2021;162:bqaa202.

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.

Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial. Curtis EM et al. American Journal of Clinical Nutrition. 2021. Secondary analysis of MAVIDOS.

Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Fudge NJ, Kovacs CS. Endocrinology. 2010;151:886 to 895. Abstract inspected; full principal unavailable.

Calcium and Phosphate Metabolism and Related Disorders During Pregnancy and Lactation. Kovacs CS. Endotext. Updated 12 October 2024. Relevant pregnancy and FGF23-disorder sections assessed; not the entire chapter.

Related reading

Original sources

Source

Maternal loss of 24-hydroxylase causes increased intestinal calcium absorption and hypercalcemia during pregnancy but reduced skeletal resorption during lactation in mice

Published in Maekawa AS et al. Journal of Bone and Mineral Research (2024).

Publication details

Maternal loss of 24-hydroxylase causes increased intestinal calcium absorption and hypercalcemia during pregnancy but reduced skeletal resorption during lactation in mice. Maekawa AS et al. Journal of Bone and Mineral Research. 2024;39:1793 to 1808.

Read more →
Source

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness

Published in Hollis BW et al. Journal of Bone and Mineral Research (2011).

Publication details

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.

Read more →
Source

Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness.

Publication details

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.

Read more →
Source

Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial

Published in Curtis EM et al. American Journal of Clinical Nutrition (2021).

Publication details

Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial. Curtis EM et al. American Journal of Clinical Nutrition. 2021. Secondary analysis of MAVIDOS.

Read more →